03.01.2022 - CAMBRIDGE, Mass., Jan. 03, 2022 (GLOBE NEWSWIRE) - Immuneering Corporation (Nasdaq: IMRX), a biopharmaceutical company advancing a robust pipeline of oncology and neuroscience product candidates that are designed to uniquely disrupt cellular . Seite 1
Immuneering Added to the Nasdaq Biotechnology Index forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.